|
|
|
|
|
|
|
|
open access
In 2014, the Gynecologic
Oncology Committee of FIGO revised the staging to incorporate ovarian,
fallopian tube, and peritoneal cancer in the same system. Changing the
staging system required extensive international consultation. The
primary site (i.e. ovary, fallopian tube, or peritoneum) is designated,
where possible. When it is not possible to clearly delineate the primary
site, these should be listed as “undesignated” [1] and [2].
It has been presumed that fallopian tube malignancies were rare [2].....Article outline
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.